Medicinal composition for treating chronic cholecystitis

A technology of chronic cholecystitis and composition, applied in the field of pharmaceutical composition, can solve problems such as gallbladder hypofunction, loss of function, gallbladder atrophy, etc., and achieve good therapeutic effect and remarkable effect

Inactive Publication Date: 2012-04-11
孔繁化
View PDF2 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Chronic cholecystitis can sometimes be the sequelae of acute cholecystitis, but most patients have not suffered from acute cholecystitis in the past. Due to long-term inflammation of the gallbladder, the gallbladder

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition for treating chronic cholecystitis
  • Medicinal composition for treating chronic cholecystitis
  • Medicinal composition for treating chronic cholecystitis

Examples

Experimental program
Comparison scheme
Effect test

experiment example

[0019] 1. Clinical observation

[0020] The treatment group selected capsules of the present invention (prepared according to the method of Example 1) to treat 100 cases of chronic cholecystitis, including 50 cases of males and 50 cases of females.

[0021] The control group selected Jigucao Capsules, produced by Guangxi Yulin Pharmaceutical Co., Ltd., to treat 100 cases of chronic cholecystitis, including 50 males and 50 females.

[0022] 2. Drug selection

[0023] Treatment group: capsules of the present invention (prepared according to the method of Example 1), specification: 0.6 g per capsule, orally, 3 times a day, 2 capsules each time.

[0024] Control group: Jigucao Capsules, produced by Guangxi Yulin Pharmaceutical Co., Ltd., specifications: 0.5g per capsule, orally, 3 times a day, 4 capsules each time.

[0025] 3. Diagnostic criteria

[0026] (1) Symptoms of indigestion, such as epigastric discomfort, aggravated by influx of greasy food. At the same time, there ar...

experiment example 2

[0042] Experimental example two, typical case

[0043] Case 1: Wu, male, 39 years old, the patient had recurrent right upper abdominal distension and pain for 1 month, had a history of alcoholism, was erratic during the pain attack, reduced diet, had a stool once a day, white and greasy fur, and a stringy pulse. Tenderness in the gallbladder area was negative. B-diagnosed as sediment-like gallstones and chronic cholecystitis.

[0044] Analysis: due to stagnation in diet, stagnant heat in the liver and stomach.

[0045] Treatment: digestion and stagnation, gallbladder dehumidification.

[0046] By taking capsules of the present invention (prepared according to the method of Example 1) to treat a course of treatment (each course of treatment is 9 days), abdominal distention disappears, pain weakens, and diet takes a turn for the better. Continue to take three courses for the treatment of and disappear through inspection silt, and health has returned to normal basically.

[0...

Embodiment 1

[0053] Embodiment 1 capsule

[0054]

[0055]The above-mentioned medicine is added into conventional auxiliary materials according to the conventional process to make capsules, each 0.6g, orally, 3 times a day, 2 capsules each time.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicinal composition for treating chronic cholecystitis, which is prepared from Chinese thorowax root, white paeony root, pawpaw, immature bitter orange, costus root, rhizoma corydalis, szechwan chinaberry fruit, oriental wormwood, Chinese rhubarb, desmodium, hawthorn, liquoric root, curcuma zedoary, stem of noble, turmeric root tuber, coptis chinensis, pangolin, Chinese honeylocust spine, honeysuckle and scirpus fluviatilis. The medicinal composition is added with common auxiliary materials to be processed into clinically acceptable tablets, capsules, granules, pills, powder or oral liquid by the conventional method. The medicinal composition disclosed by the invention has the effects of soothing liver-gallbladder, regulating qi, removing dampness, relieving dyspepsia, activating meridians and relieving pain, and has good treatment effects on chronic cholecystitis caused by various factors. The treatment effect of the medicinal composition is obvious.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating chronic cholecystitis. Background technique [0002] Chronic cholecystitis is the most common gallbladder disease. Patients generally have gallstones at the same time, but chronic cholecystitis patients without stones are not uncommon in our country. Chronic cholecystitis can sometimes be the sequelae of acute cholecystitis, but most patients have not suffered from acute cholecystitis in the past. Due to long-term inflammation of the gallbladder, the gallbladder wall will thicken with fibers, and the scar shrinks, causing the gallbladder to shrink and the cyst cavity can be completely closed , leading to hypofunction of the gallbladder, or even complete loss of function. [0003] Chronic cholecystitis belongs to the category of "hypochondriac pain" in traditional Chinese medicine, "hypochondriac pain" was first seen in "Internal Classics" ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/9066A61P1/16A61K35/36
Inventor 孔繁化
Owner 孔繁化
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products